We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-3.5%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.91B
AUM Growth
-$168M
Cap. Flow
-$5.79M
Cap. Flow %
-0.2%
Top 10 Hldgs %
19.63%
Holding
3,182
New
46
Increased
373
Reduced
770
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 20.9%
2 Financials 10.2%
3 Industrials 9.77%
4 Consumer Discretionary 9.34%
5 Healthcare 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FXH icon
2951
First Trust Health Care AlphaDEX Fund
FXH
$1.11B
$5.18K ﹤0.01%
50
SPCE icon
2952
Virgin Galactic
SPCE
$460M
$5.14K ﹤0.01%
1,698
FRGE
2953
DELISTED
Forge Global Holdings
FRGE
$5.1K ﹤0.01%
605
EEX
2954
DELISTED
Emerald Holding
EEX
$5.07K ﹤0.01%
1,289
CLPR
2955
Clipper Realty
CLPR
$52.5M
$5.04K ﹤0.01%
1,313
ISPR icon
2956
Ispire Technology
ISPR
$96.4M
$5.01K ﹤0.01%
1,837
STEM icon
2957
Stem
STEM
$55.2M
$4.96K ﹤0.01%
708
VCSA
2958
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$4.94K ﹤0.01%
918
CSTE icon
2959
Caesarstone
CSTE
$108M
$4.93K ﹤0.01%
2,028
VRA icon
2960
Vera Bradley
VRA
$94.7M
$4.87K ﹤0.01%
2,166
XHB icon
2961
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
$4.84K ﹤0.01%
+50
New +$5.18K
CRVO icon
2962
CervoMed
CRVO
$40.7M
$4.84K ﹤0.01%
529
XAR icon
2963
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.61B
$4.82K ﹤0.01%
30
LCTX icon
2964
Lineage Cell Therapeutics
LCTX
$271M
$4.81K ﹤0.01%
10,656
CABA icon
2965
Cabaletta Bio
CABA
$444M
$4.78K ﹤0.01%
3,452
BIOA
2966
BioAge Labs
BIOA
$490M
$4.77K ﹤0.01%
1,269
JSPR icon
2967
Jasper Therapeutics
JSPR
$28.8M
$4.77K ﹤0.01%
1,109
ITA icon
2968
iShares US Aerospace & Defense ETF
ITA
$14.9B
$4.75K ﹤0.01%
31
CTNM
2969
Contineum Therapeutics
CTNM
$595M
$4.75K ﹤0.01%
680
BBH icon
2970
VanEck Biotech ETF
BBH
$428M
$4.72K ﹤0.01%
30
IVVD icon
2971
Invivyd
IVVD
$204M
$4.7K ﹤0.01%
7,770
PYXS icon
2972
Pyxis Oncology
PYXS
$203M
$4.69K ﹤0.01%
4,784
ANRO icon
2973
Alto Neuroscience
ANRO
$1.28B
$4.67K ﹤0.01%
2,164
LVO icon
2974
LiveOne
LVO
$57.7M
$4.66K ﹤0.01%
667
BLUE
2975
DELISTED
bluebird bio
BLUE
$4.66K ﹤0.01%
954

Similar funds

Ameritas Investment Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Ameritas Investment Partners held 3,182 positions worth $2.91B, down 5.5% from $3.08B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 3%. Ameritas Investment Partners opened 46 new positions and exited 50, leaving the 3,182-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

  • Ameritas Investment Partners's largest Q1 2025 buy was WisdomTree US Value Fund: 111,735 shares worth $9.18M.
  • Ameritas Investment Partners added most to Verizon in Q1 2025, an estimated $2.18M increase.
  • Ameritas Investment Partners's biggest Q1 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $12M.
  • Ameritas Investment Partners fully exited Altair Engineering Inc in Q1 2025, selling an estimated $1.93M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.91B portfolio in Q1 2025.
  • Ameritas Investment Partners opened 46 new positions and closed 50 in Q1 2025.
  • Ameritas Investment Partners's portfolio value fell 5.5% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.